Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil

International Journal of Clinical Oncology

Volumn 19, Issue 2, 2014, Pages 247-253

  Lee, Sung Hak ^a   Choi, Eun Ji ^a   Kim, Min Sik ^a   Park, Jun Wook ^a   Lee, Youn Soo ^a   Kim, Su Young ^a   Kang, Chang Suk ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Expression; Prognosis; Squamous cell carcinoma; Syndecan 1; Tonsil

Indexed keywords

SYNDECAN 1;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COPY NUMBER VARIATION; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; TUMOR DIFFERENTIATION; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; PAPILLOMA VIRUS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TONSIL TUMOR; VIROLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PROGNOSIS; SYNDECAN-1; TONSILLAR NEOPLASMS;

EID: 84899960304     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0552-7     Document Type: Article

References (33)

1. Teng YH, Aquino RS, Park PW (2012) Molecular functions of syndecan-1 in disease. Matrix Biol 31:3-16
2. Rapraeger AC (2001) Molecular interactions of syndecans during development. Semin Cell Dev Biol 12:107-116
3. Bernfield M, Gotte M, Park PW et al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777 (Pubitemid 29449208)
4. Anttonen A, Kajanti M, Heikkila P et al (1999) Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer 79:558-564 (Pubitemid 29046236)
5. Al-Shibli K, Al-Saad S, Andersen S et al (2010) The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138- positive cells in non-small cell lung carcinoma. APMIS 118:371-382
6. Anttonen A, Heikkila P, Kajanti M et al (2001) High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer 32:297-305 (Pubitemid 32487690)
7. Kim YI, Lee A, Lee BH et al (2011) Prognostic significance of syndecan-1 expression in cervical cancers. J Gynecol Oncol 22:161-167
8. Shimada K, Nakamura M, De Velasco MA et al (2010) Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma. Cancer Sci 101:155-160
9. Rasmussen T, Lodahl M, Hancke S et al (2004) In multiple myeloma clonotypic CD38-/CD19+/CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes. Leuk Lymphoma 45:1413-1417 (Pubitemid 38701919)
10. Huff CA, Matsui W (2008) Multiple myeloma cancer stem cells. J Clin Oncol 26:2895-2900
11. Alexander CM, Reichsman F, Hinkes MT et al (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25:329-332 (Pubitemid 30437323)
12. Joensuu H, Anttonen A, Eriksson M et al (2002) Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 62:5210-5217 (Pubitemid 35024592)
13. Seidel C, Sundan A, Hjorth M et al (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood 95:388-392 (Pubitemid 30041645)
14. Roh YH, Kim YH, Choi HJ et al (2008) Syndecan-1 expression in gallbladder cancer and its prognostic significance. Eur Surg Res 41:245-250
15. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
16. Moon SH, Choi JY, Lee HJ et al (2012) Prognostic value of (18) F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters. Head Neck 35(1):15-22
17. Lee SY, Park SY, Kim SH et al (2011) Expression of matrix metalloproteinases and their inhibitors in squamous cell carcinoma of the tonsil and their clinical significance. Clin Exp Otorhinolaryngol 4:88-94
18. Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294-4301
19. St Guily JL, Clavel C, Okais C et al (2011) Human papillomavirus genotype distribution in tonsil cancers. Head Neck Oncol 3:6
20. Patel SG, Shah JP (2005) TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242-58; quiz 261-262, 264
21. Poulsen M, Porceddu SV, Kingsley PA et al (2007) Locally advanced tonsillar squamous cell carcinoma: treatment approach revisited. Laryngoscope 117:45-50 (Pubitemid 46066061)
22. Lindquist D, Romanitan M, Hammarstedt L et al (2007) Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1:350-355 (Pubitemid 350186274)
23. Mennerich D, Vogel A, Klaman I et al (2004) Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer 40:1373-1382 (Pubitemid 38737024)
24. Mukunyadzi P, Liu K, Hanna EY et al (2003) Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol 16:796-801 (Pubitemid 37011075)
25. Hammarstedt L, Dahlstrand H, Lindquist D et al (2007) The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127:988-992 (Pubitemid 47345807)
26. Hammarstedt L, Lindquist D, Dahlstrand H et al (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620-2623 (Pubitemid 44691317)
27. Inki P, Joensuu H, Grenman R et al (1994) Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 70:319-323 (Pubitemid 24247157)
28. Ramani VC, Pruett PS, Thompson CA et al (2012) Heparan sulfate chains of syndecan-1 regulate ectodomain shedding. J Biol Chem 287:9952-9961
29. Vered M, Dayan D, Yahalom R et al. Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer 127:1356-1362
30. Ito Y, Yoshida H, Nakano K et al (2003) Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation. Histopathology 43:157-164 (Pubitemid 36963160)
31. Maeda T, Desouky J, Friedl A (2006) Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene 25:1408-1412 (Pubitemid 43336469)
32. Gotte M, Kersting C, Ruggiero M et al (2006) Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer. Anticancer Res 26:621-627 (Pubitemid 43206026)
33. Roh YH, Kim YH, Choi HJ et al (2009) Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer. J Hepatobiliary Pancreat Surg 16:315-321